CNBX Pharmaceuticals Inc. (CNBX) Current Assets (2013 - 2026)
CNBX Pharmaceuticals' (CNBX) quarterly Current Assets came in at $12795.0 in Q2 2026, down 31.27% YoY from $18615.0 in Q2 2025, and down 14.12% on a QoQ basis from $14899.0 in Q1 2026.
CNBX Pharmaceuticals Inc. (CNBX) Current Assets (2013 - 2026) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 14 years of Current Assets data on file, last reported at $12795.0 in Q2 2026.
- Quarterly Current Assets fell 31.27% year-over-year to $12795.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $12795.0 (down 31.27% YoY) and the FY2025 annual result came in at $18437.0, down 41.25% from the prior year.
- Current Assets slipped to $12795.0 in Q2 2026, from $14899.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $399595.0 in Q1 2022 to a low of $11162.0 in Q4 2025.
- A 5-year average of $121596.5 and a median of $89856.0 in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets sank 89.67% — and 2023, when it jumped 51.41%.
- Tracing CNBX's Current Assets over 5 years: stood at $99685.0 in 2022, then jumped by 51.41% to $150936.0 in 2023, then tumbled by 85.22% to $22308.0 in 2024, then plunged by 49.96% to $11162.0 in 2025, then grew by 14.63% to $12795.0 in 2026.
- The last three Current Assets figures came in at $12795.0 (Q2 2026), $14899.0 (Q1 2026), and $11162.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 12,795.00 |
| Feb 28, 2026 | 14,899.00 |
| Nov 30, 2025 | 11,162.00 |
| Aug 31, 2025 | 18,437.00 |
| May 31, 2025 | 18,615.00 |
| Feb 28, 2025 | 50,660.00 |
| Nov 30, 2024 | 22,308.00 |
| Aug 31, 2024 | 31,383.00 |
| May 31, 2024 | 80,027.00 |
| Feb 29, 2024 | 163,917.00 |
| Nov 30, 2023 | 150,936.00 |
| Aug 31, 2023 | 224,308.00 |
| May 31, 2023 | 348,796.00 |
| Feb 28, 2023 | 108,835.00 |
| Nov 30, 2022 | 99,685.00 |
| Aug 31, 2022 | 198,287.00 |
| May 31, 2022 | 234,092.00 |
| Feb 28, 2022 | 399,595.00 |
| Nov 30, 2021 | 964,586.00 |
| Aug 31, 2021 | 1.59 Mn |